Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Cancer, Resected”

244 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 244 results

Large-scale testing (Phase 3)Ended earlyNCT00014651
What this trial is testing

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

Who this might be right for
Pancreatic CancerPerioperative/Postoperative Complications
Mayo Clinic
Early research (Phase 1)Ended earlyNCT03956056
What this trial is testing

Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Who this might be right for
Pancreas CancerPancreatic CancerCancer of the Pancreas
Washington University School of Medicine 12
Not applicableLooking for participantsNCT07173257
What this trial is testing

PROMs After Pancreatectomy

Who this might be right for
Pancreas NeoplasmsPancreatitisPancreatic Cyst
University of Arizona 250
Early research (Phase 1)UnknownNCT04810910
What this trial is testing

Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Who this might be right for
Resectable Pancreatic Cancer
Zhejiang Provincial People's Hospital 20
Not applicableStudy completedNCT01368094
What this trial is testing

Early (4 Days) Versus Standard Drainage of the Abdominal Cavity After Pancreaticoduodenectomy

Who this might be right for
Pancreatic DiseasePancreatic Neoplasms
Centre Hospitalier Universitaire, Amiens 141
Not applicableStudy completedNCT04151394
What this trial is testing

Side-to-side Duodenojejunostomy After Distal Duodenal Resection (DUORESECT)

Who this might be right for
Duodenal NeoplasmGastrointestinal DiseaseSurgery--Complications+1 more
Universidad de Extremadura 13
Early research (Phase 1)Ended earlyNCT01198522
What this trial is testing

Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical Resection
Philogen S.p.A. 28
Early research (Phase 1)Ended earlyNCT04281290
What this trial is testing

Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study)

Who this might be right for
Pancreas Cancer
University Medical Centre Ljubljana 3
Not applicableLooking for participantsNCT06574620
What this trial is testing

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Who this might be right for
Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal Adenocarcinoma+1 more
British Columbia Cancer Agency 200
Large-scale testing (Phase 3)Looking for participantsNCT04969731
What this trial is testing

Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
GC Cell Corporation 408
Not applicableUnknownNCT04136522
What this trial is testing

Usefulness of the Artery First Approach in Pancreatic Cancer Surgery

Who this might be right for
Pancreatic Cancer, AdultMargin, Tumor-FreeSurgery Site Fistula+1 more
Asan Medical Center 268
Not applicableLooking for participantsNCT05524090
What this trial is testing

PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic AdenocarcinomaPancreatic Adenocarcinoma Non-resectable+1 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 223
Not applicableNot Yet RecruitingNCT06381882
What this trial is testing

The Role of the Human Microbiome in Patients After Pancreatic Resection.

Who this might be right for
Pancreas CancerPancreas NeoplasmPancreas Adenocarcinoma+3 more
St. Antonius Hospital 200
Not applicableLooking for participantsNCT04571294
What this trial is testing

Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy

Who this might be right for
Pancreas CancerPancreaticoduodenal LymphadenopathyPancreas Adenocarcinoma
Humanitas Hospital, Italy 180
Not applicableStudy completedNCT04747600
What this trial is testing

Outcomes of Surgical Resection of Pancreatic Cystic Neoplasms Based on the European Expert Consensus Statement: A Prospective Observational Study.

Who this might be right for
Pancreas Cancer
Zagazig University 63
Testing effectiveness (Phase 2)WithdrawnNCT02310971
What this trial is testing

Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas

Who this might be right for
Pancreatic Carcinoma Stage IPancreatic Carcinoma Stage II
Prima BioMed Ltd
Not applicableLooking for participantsNCT06228599
What this trial is testing

Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence

Who this might be right for
Pancreas Cancer
Medical College of Wisconsin 40
Not applicableUnknownNCT01411072
What this trial is testing

Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer

Who this might be right for
Pancreas Cancer
AHS Cancer Control Alberta 20
Testing effectiveness (Phase 2)Looking for participantsNCT04858334
What this trial is testing

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Who this might be right for
Pancreatic Acinar Cell CarcinomaPancreatic Adenosquamous CarcinomaPancreatic Squamous Cell Carcinoma+4 more
National Cancer Institute (NCI) 152
Large-scale testing (Phase 3)Looking for participantsNCT07252232
What this trial is testing

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic CancerPDACPDAC - Pancreatic Ductal Adenocarcinoma+2 more
Revolution Medicines, Inc. 500
Load More Results